biotech / news / / GlobeNewswire
The Blincyto market size has shown robust growth.
Blincyto market size is expected to grow from $0.81M in 2025 to $1.08M by 2030.
KEY POINTS
- In 2024, Blincyto received FDA approval for B-cell precursor acute lymphoblastic leukemia treatment.
- Tariffs have increased imported raw material costs, affecting oncology treatment affordability in Asia-Pacific and Latin America.
- Asia Pacific is anticipated to experience the fastest Blincyto market growth during the forecast period.
COMPANIES
Summarized by Newsio from GlobeNewswire. How we summarize →